SR

Shanu Rastogi

Director Director DIN 07414532
DIN 07414532 First appointment May 2016 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since May 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Shanu Rastogi

Data last updated:

Shanu Rastogi was a Director at Archaea Pharma (India) Private Limited (2016–2018) and Designated Partner at Central Homeo Agencies Llp (from 2019). The companies operate in Pharma.

DIN 07414532
Primary Designation Director
Industry Pharma
First Appointment 26 May 2016
Oldest Company Age 7 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 May 20162016₹10.1 Lakh (FY 2024)Active
Designated Partner14 Feb 20192019Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Central Homeo Agencies Llp
Archaea Pharma (India) Private Limited
Premium access

Shareholding and investment profile for Shanu Rastogi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shanu Rastogi

Shanu Rastogi was first appointed on 26 May 2016 as Director at Archaea Pharma (India) Private Limited. The most recent appointment on record is 14 Feb 2019 at Central Homeo Agencies Llp.

Shanu Rastogi held 2 earlier board appointments: Archaea Pharma (India) Private Limited (Director, 26 May 2016 to 01 Aug 2018); Central Homeo Agencies Llp (Designated Partner, from 14 Feb 2019).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available